Author Correction: MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway

Authors :: Hong-Hao Zhou
Ji-Ye Yin
Wei Zhang
Yi-Xin Chen
Zhao-Qian Liu
Hsuan-Shun Huang
Na-Yiyuan Wu
Xiang-Ping Li
Chao Fang
Source :: Scientific Reports, Vol 11, Iss 1, Pp 1-3 (2021)
Publication Year :: 2021
Publisher :: Nature Portfolio, 2021.

Subjects :: Cisplatin
Multidisciplinary
business.industry
Science
non-small cell lung cancer (NSCLC)
medicine.disease
Text mining
Cancer research
Medicine
Signal transduction
business
medicine.drug

Tools